Details
Stereochemistry | RACEMIC |
Molecular Formula | C15H11ClN2O2 |
Molecular Weight | 286.713 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
InChI
InChIKey=ADIMAYPTOBDMTL-UHFFFAOYSA-N
InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)
Molecular Formula | C15H11ClN2O2 |
Molecular Weight | 286.713 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:12:21 UTC 2023
by
admin
on
Fri Dec 15 16:12:21 UTC 2023
|
Record UNII |
6GOW6DWN2A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175694
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
||
|
DEA NO. |
2835
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
||
|
WHO-ATC |
N05BA04
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
||
|
NDF-RT |
N0000007542
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
||
|
WHO-VATC |
QN05BA04
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
||
|
LIVERTOX |
NBK548104
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7823
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
4616
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
604-75-1
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
OXAZEPAM
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
169448
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
m8295
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL568
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
DTXSID1021087
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
2015
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
6GOW6DWN2A
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
Oxazepam
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
7781
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | RxNorm | ||
|
3140
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
1483006
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
DB00842
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
D010076
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
SUB09506MIG
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
1507
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
6GOW6DWN2A
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
C47642
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
7253
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
100000091921
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY | |||
|
210-076-9
Created by
admin on Fri Dec 15 16:12:21 UTC 2023 , Edited by admin on Fri Dec 15 16:12:21 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BINDER->LIGAND |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
TRACE IN URINE; NOT IN PLASMA
MINOR
URINE
|
||
|
PARENT -> METABOLITE ACTIVE | |||
|
PARENT -> METABOLITE ACTIVE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 1.1
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 4.0
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||